Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin
Authors:
- 1 January 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 21 (1) , 1-9
Abstract
Breast cancer is the second leading cause of cancer deaths among women in the United States. Several treatment options exist, with different side effects. To alleviate the side effects, several research groups have studied chemotherapeutic effects of plant compounds on cancer cells. These could be used as an alternative treatment option either alone or in combination with other chemotherapeutic drugs. The aim of this study was to evaluate the activity of a combination of perillyl alcohol (POH), methyl jasmonate (MJ) with cisplatin to define the most effective schedule and to investigate the mechanism of action in breast cancer cells. POH and MJ treatment (20% decrease in cell viability concentration) enhanced the cytotoxicity for subsequent exposure to cisplatin in MDA-MB-435 and MDA-MB-231 cells. Combination treatment of POH and MJ blocked cells at the G0/G1 phase of the cell cycle and the addition of cisplatin forced the cells to progress through the cell cycle and induced apoptosis. Apoptotic mechanistic studies indicated that POH and MJ treatment activated tumor necrosis factor receptor 1 and this was further increased by the addition of cisplatin. It was also found that mitochondrial membrane potential decreased with POH and MJ treatment; this effect was further enhanced by cisplatin treatment. These findings contributed to a better understanding of molecular mechanism of apoptosis in combination treatment of POH, MJ, and cisplatin. Results also showed that the combination treatment of three drugs is more effective than single drug alone or two drugs together.Keywords
This publication has 25 references indexed in Scilit:
- Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cellsAnti-Cancer Drugs, 2008
- Disruption of the hexokinase–VDAC complex for tumor therapyOncogene, 2008
- Delayed Cytotoxic Effects of Methyl Jasmonate and cis-Jasmone Induced Apoptosis in Prostate Cancer CellsCancer Investigation, 2008
- Reactive oxygen species and mitochondrial membrane potential are modulated during CDDP-induced apoptosis in EC-109 cellsThis paper is one of a selection of papers in this Special Issue, entitled International Symposium on Recent Advances in Molecular, Clinical, and Social Medicine, and has undergone the Journal's usual peer-review process.Biochemistry and Cell Biology, 2007
- In vitro Induction of Apoptosis in U937 Cells by Perillyl Alcohol with Sensitization by Pentoxifylline: Increased BCL-2 and BAX Protein ExpressionChemotherapy, 2006
- JASMONATES INDUCE APOPTOSIS AND CELL CYCLE ARREST IN NON-SMALL CELL LUNG CANCER LINESExperimental Lung Research, 2006
- Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cellsThe Prostate, 2003
- Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin‐ and carboplatin‐induced growth inhibition and apoptotic deathInternational Journal of Cancer, 2003
- Molecular machinery and signaling events in apoptosisDrug Development Research, 2001
- Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell linesNutrition and Cancer, 1998